Sensors are disclosed that detect whether a cannula is properly inserted to its full depth in a subject's skin. The sensors may be used with a blood glucose monitor, or with a continuous insulin infusion pump, infusion set, or other system involving intermittent or continuous testing and/or drug delivery.

Systems and methods to provide an ultrasound scanner with a display interface are described. An ultrasound system includes an ultrasound scanner having an interface configured to display a visual representation, and a first transceiver configured to communicate over a communication link. The ultrasound system includes a display device having a reader configured to read the visual representation displayed by the ultrasound scanner, and a second transceiver configured to, responsive to the reader reading the visual representation, initiate communication with the first transceiver of the ultrasound scanner over the communication link to pair the ultrasound scanner and the display device.

A marker system includes a biopsy apparatus having a cannula and a stylet. The cannula has a distal end, the stylet has a distal stylet tip, and the stylet is received in the cannula. A tissue marker is coupled to the distal stylet tip. The tissue marker is configured to be contacted by the distal end of the cannula. The tissue marker is detached from the stylet distal tip by either of a proximal movement of the stylet relative to the cannula or a distal movement of the cannula relative to the stylet.

Methods and devices are provided for preparing and implanting tissue scaffolds. Various embodiments of scribing tools are provided that are configured to mark one or more predetermined shapes around a defect site in tissue. The shape or shapes marked in tissue can be used to cut a tissue scaffold having a shape that matches the shape or shapes marked in tissue. In one embodiment, the scribing tool used to mark a shape in tissue can also be used to cut the tissue scaffold.

A biopsy site marker configured to expand upon deployment into a biopsy cavity, and visible under several different imaging modalities, comprises a superabsorbent hydrogel component and a radiopaque element. The hydrogel is in a compressed, dehydrated state prior to deployment to facilitate placement of the marker within the biopsy site, and thereafter expands upon deployment in the biopsy site. Such expansion limits migration of the site marker.

Method and contact lens (3) for measuring a subject's three dimensional eye movement including torsional movement. A video camera (1) is provided for recording an image of the subject's eye (2). The contact lens (3) is provided for placement over the subject's eye (2). The contact lens (3) comprises one or more markers (3a,3b) that are detectable by the video camera (1) and are positioned at a lateral offset (D) with respect to a central part (3p) of the contact lens (3). The one or more markers (3a,3b) are configured for detecting torsional rotation (R) of the subject's eye (2) around a line of sight axis (C) of the subject's eye (2) by using the video camera (1) to track a position of the one or more markers (3a,3b).

A method of electrically stimulating a target muscle of a patient includes placing at least one stimulation electrode in electrical contact with the target muscle and applying an electrical signal to the stimulation electrode. The method further includes obtaining a signal from a sensing element placed on the patient, wherein the sensing element is configured to detect at least one biological parameter of the patient associated with contraction of the target muscle caused by the application of the electrical signal, and adapting stimulation of the target muscle by the at least one stimulation electrode using the obtained signal.

A biopsy device includes a biopsy sample extraction needle having a sample extraction end, a recovery end, and a transport channel linking the extraction and recovery ends. In a first configuration, a valve has a first position wherein the valve directly connects a pump to an ambient vent and the pump can reduce the pressure in at least the sample extraction end. In a second configuration, the valve has a second position wherein the valve directly connects the pump to a fluid reservoir and the pump can draw fluid from the fluid reservoir. In a third configuration, the valve has a third position wherein the valve directly connects the pump to the extraction end and the pump can supply fluid to the extraction end to flush fluid along the transport channel from the extraction end to the recovery end to transport a sample along the transport channel.

A biopsy site marker configured to expand upon deployment into a biopsy cavity, and visible under several different imaging modalities, comprises a superabsorbent hydrogel component and a radiopaque element. The hydrogel is in a compressed, dehydrated state prior to deployment to facilitate placement of the marker within the biopsy site, and thereafter expands upon deployment in the biopsy site. Such expansion limits migration of the site marker.

Embodiments of the invention provide a system and method for resecting a tissue mass. The system for resecting a tissue mass includes a surgical instrument and a first sensor for measuring a signal corresponding to the position and orientation of the tissue mass. The first sensor is dimensioned to fit insider or next to the tissue mass. The system also includes a second sensor attached to the surgical instrument configured to measure the position and orientation of the surgical instrument. The second sensor is configured to receive the signal from the first sensor. A controller is in communication with the first sensor and/or the second sensor, and the controller executes a stored program to calculate a distance between the first sensor and the second sensor. Accordingly, visual, auditory, haptic or other feedback is provided to the clinician to guide the surgical instrument to the surgical margin.